{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:43:40Z","timestamp":1790613820249,"version":"4.1.0"},"reference-count":174,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01032","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:15:57Z","timestamp":1526256957000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Animal Models to Study Hepatitis C Virus Infection"],"prefix":"10.3389","volume":"9","author":[{"given":"Rani","family":"Burm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Collignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Atef","family":"Mesalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Meuleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/ilar\/ilx028","article-title":"The Chimpanzee model of viral hepatitis: advances in understanding the immune response and treatment of viral hepatitis","volume":"58","author":"Lanford","year":"2017","journal-title":"ILAR J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13652","article-title":"Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation","author":"Beinhardt","year":"2017","journal-title":"Liver Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12985-015-0450-x","article-title":"The role of HCV proteins on treatment outcomes","volume":"12","author":"Kumthip","year":"2015","journal-title":"Virol J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","article-title":"Efficient initiation of HCV RNA replication in cell culture","volume":"290","author":"Blight","year":"2000","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.1082604","article-title":"Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease","volume":"300","author":"Foy","year":"2003","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S0016-5085(99)70290-8","article-title":"Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate","volume":"117","author":"Baumert","year":"1999","journal-title":"Gastroenterology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6865","DOI":"10.1128\/JVI.76.14.6865-6872.2002","article-title":"Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins","volume":"76","author":"Buonocore","year":"2002","journal-title":"J Virol"},{"key":"B11","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1128\/JVI.73.8.6782-6790.1999","article-title":"Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein","volume":"73","author":"Flint","year":"1999","journal-title":"J Virol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1128\/JVI.72.5.3539-3546.1998","article-title":"Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus","volume":"72","author":"Lagging","year":"1998","journal-title":"J Virol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/viro.2001.0971","article-title":"Characterization of pseudotype VSV possessing HCV envelope proteins","volume":"286","author":"Matsuura","year":"2001","journal-title":"Virology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7271","DOI":"10.1073\/pnas.0832180100","article-title":"Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1\u2013E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0014-5793(03)00635-5","article-title":"Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins","volume":"546","author":"Drummer","year":"2003","journal-title":"FEBS Lett"},{"key":"B17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/jmv.1055","article-title":"Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient*","volume":"64","author":"Kato","year":"2001","journal-title":"J Med Virol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm0805-905b","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.antiviral.2014.01.007","article-title":"Murine models of hepatitis C: what can we look forward to?","volume":"104","author":"von Schaewen","year":"2014","journal-title":"Antiviral Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/hep.26626","article-title":"Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells","volume":"59","author":"Frentzen","year":"2014","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"41003","DOI":"10.1074\/jbc.M302267200","article-title":"Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate","volume":"278","author":"Barth","year":"2003","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor","volume":"96","author":"Agnello","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1128\/JVI.01888-08","article-title":"Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection","volume":"83","author":"Liu","year":"2009","journal-title":"J Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10777","DOI":"10.1073\/pnas.1301764110","article-title":"Identification of transferrin receptor 1 as a hepatitis C virus entry factor","volume":"110","author":"Martin","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","first-page":"8433","DOI":"10.1128\/JVI.00081-14","article-title":"Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes","volume":"88","author":"Wu","year":"2014","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7620","DOI":"10.1073\/pnas.1602701113","article-title":"Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition","volume":"113","author":"Li","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nature10168","article-title":"A genetically humanized mouse model for hepatitis C virus infection","volume":"474","author":"Dorner","year":"2011","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/ilar.42.2.117","article-title":"The chimpanzee model of hepatitis C virus infections","volume":"42","author":"Lanford","year":"2001","journal-title":"ILAR J"},{"key":"B38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-0684.1988.tb00386.x","article-title":"Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee","volume":"17","author":"Muchmore","year":"1988","journal-title":"J Med Primatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1073\/pnas.87.16.6441","article-title":"Early events in hepatitis C virus infection of chimpanzees","volume":"87","author":"Shimizu","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e76501","DOI":"10.1371\/journal.pone.0076501","article-title":"Kinetics of miR-122 expression in the liver during acute HCV infection","volume":"8","author":"Choi","year":"2013","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0165533","DOI":"10.1371\/journal.pone.0165533","article-title":"Elevation of alanine aminotransferase activity occurs after activation of the cell-death signaling initiated by pattern-recognition receptors but before activation of cytolytic effectors in NK or CD8+T cells in the liver during acute HCV infection","volume":"11","author":"Choi","year":"2016","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"Cooper","year":"1999","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4049\/jimmunol.172.1.483","article-title":"Conserved hierarchy of helper T cell responses in a chimpanzee during primary and secondary hepatitis C virus infections","volume":"172","author":"Shoukry","year":"2004","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees","volume":"12","author":"Folgori","year":"2006","journal-title":"Nat Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000050040","article-title":"Studies of hepatitis C virus in chimpanzees and their importance for vaccine development","volume":"44","author":"Bukh","year":"2001","journal-title":"Intervirology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1002895","DOI":"10.1371\/journal.ppat.1002895","article-title":"Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees","volume":"8","author":"Morin","year":"2012","journal-title":"PLoS Pathog"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/cmdc.201300343","article-title":"Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity","volume":"8","author":"Coburn","year":"2013","journal-title":"ChemMedChem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/AAC.01032-08","article-title":"Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees","volume":"53","author":"Carroll","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1128\/AAC.00723-07","article-title":"Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model","volume":"51","author":"Chen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B50","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1128\/AAC.00990-10","article-title":"Sustained viral response in a hepatitis C virus-infected chimpanzee via a combination of direct-acting antiviral agents","volume":"55","author":"Olsen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"B51","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1053\/j.gastro.2013.07.026","article-title":"Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection","volume":"145","author":"Sourisseau","year":"2013","journal-title":"Gastroenterology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/hep.27773","article-title":"Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice","volume":"62","author":"Scull","year":"2015","journal-title":"Hepatology"},{"key":"B53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0684.1993.tb00697.x","article-title":"Lack of susceptibility of various primates and woodchucks to hepatitis C virus","volume":"22","author":"Abe","year":"1993","journal-title":"J Med Primatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1128\/JVI.01448-09","article-title":"Pathogenesis of hepatitis C virus infection in Tupaia belangeri","volume":"84","author":"Amako","year":"2010","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1099\/jgv.0.000869","article-title":"Tree shrew, a potential animal model for hepatitis C, supports the infection and replication of HCV in vitro and in vivo","volume":"98","author":"Feng","year":"2017","journal-title":"J Gen Virol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3892\/ijmm.2015.2063","article-title":"A zebrafish model for subgenomic hepatitis C virus replication","volume":"35","author":"Ding","year":"2015","journal-title":"Int J Mol Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tox.2007.09.007","article-title":"Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio","volume":"243","author":"Rekha","year":"2008","journal-title":"Toxicology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/gut.2005.085050","article-title":"The hepatitis C virus and immune evasion: non-structural 3\/4A transgenic mice are resistant to lethal tumour necrosis factor \u03b1 mediated liver disease","volume":"55","author":"Frelin","year":"2006","journal-title":"Gut"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1099\/0022-1317-76-12-3031","article-title":"Expression of hepatitis C virus envelope proteins in transgenic mice","volume":"76","author":"Koike","year":"1995","journal-title":"J Gen Virol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.510250437","article-title":"Transgenic expression of hepatitis C virus structural proteins in the mouse","volume":"25","author":"Kawamura","year":"1997","journal-title":"Hepatology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/hep.510250338","article-title":"Hepatitis C virus core and E2 protein expression in transgenic mice","volume":"25","author":"Pasquinelli","year":"1997","journal-title":"Hepatology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1099\/0022-1317-78-7-1527","article-title":"Hepatitis C virus core protein induces hepatic steatosis in transgenic mice","volume":"78","author":"Moriya","year":"1997","journal-title":"J Gen Virol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice","volume":"4","author":"Moriya","year":"1998","journal-title":"Nat Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.20621","article-title":"Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis","volume":"41","author":"Kamegaya","year":"2005","journal-title":"Hepatology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ijc.23056","article-title":"Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis","volume":"122","author":"Tanaka","year":"2008","journal-title":"Int J Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e5025","DOI":"10.1371\/journal.pone.0005025","article-title":"HCV tumor promoting effect is dependent on host genetic background","volume":"4","author":"Klopstock","year":"2009","journal-title":"PLoS One"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e51656","DOI":"10.1371\/journal.pone.0051656","article-title":"Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liver","volume":"7","author":"Sekiguchi","year":"2012","journal-title":"PLoS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1086\/498218","article-title":"In vivo clearance of hepatitis C virus nonstructural 3\/4A\u2013expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes","volume":"192","author":"Ahl\u00e9n","year":"2005","journal-title":"J Infect Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.4049\/jimmunol.1001790","article-title":"Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3\/4A-specific T cells during therapeutic vaccination","volume":"186","author":"Chen","year":"2011","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1053\/gast.2002.31001","article-title":"Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus","volume":"122","author":"Lerat","year":"2002","journal-title":"Gastroenterology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jhep.2012.04.019","article-title":"Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent","volume":"57","author":"Chouteau","year":"2012","journal-title":"J Hepatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00007890-199801150-00011","article-title":"A functional model of hepatocyte transplantation for in vivo immunologic studies","volume":"65","author":"Bumgardner","year":"1998","journal-title":"Transplantation"},{"key":"B73","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00007890-199801150-00010","article-title":"In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model","volume":"65","author":"Bumgardner","year":"1998","journal-title":"Transplantation"},{"key":"B74","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00007890-199908270-00019","article-title":"Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection","volume":"68","author":"Bumgardner","year":"1999","journal-title":"Transplantation"},{"key":"B75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jim.2014.03.006","article-title":"Visualizing hepatitis C virus infection in humanized mice","volume":"410","author":"von Schaewen","year":"2014","journal-title":"J Immunol Methods"},{"key":"B76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/infdis\/172.1.25","article-title":"Hepatitis C virus viremia in SCID \u2013 >BNX mouse chimera","volume":"172","author":"Galun","year":"1995","journal-title":"J Infect Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/hep.510290228","article-title":"The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of Anti-HBV therapeutic agents","volume":"29","author":"Ilan","year":"1999","journal-title":"Hepatology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1086\/338266","article-title":"The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV","volume":"185","author":"Ilan","year":"2002","journal-title":"J Infect Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.antiviral.2008.07.006","article-title":"The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV","volume":"80","author":"Meuleman","year":"2008","journal-title":"Antiviral Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1128\/JVI.80.6.2654-2664.2006","article-title":"Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients","volume":"80","author":"Eren","year":"2006","journal-title":"J Virol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0092-8674(90)90010-C","article-title":"Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator","volume":"62","author":"Heckel","year":"1990","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0092-8674(91)90615-6","article-title":"Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene","volume":"66","author":"Sandgren","year":"1991","journal-title":"Cell"},{"key":"B83","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1126\/science.8108734","article-title":"Replacement of diseased mouse liver by hepatic cell transplantation","volume":"263","author":"Rhim","year":"1994","journal-title":"Science"},{"key":"B85","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1073\/pnas.95.1.310","article-title":"Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma","volume":"95","author":"Petersen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B86","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1073\/pnas.92.11.4942","article-title":"Complete reconstitution of mouse liver with xenogeneic hepatocytes","volume":"92","author":"Rhim","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B87","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1053\/jhep.2001.23314","article-title":"Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus","volume":"33","author":"Dandri","year":"2001","journal-title":"Hepatology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","article-title":"Near completely humanized liver in mice shows human-type metabolic responses to drugs","volume":"165","author":"Tateno","year":"2004","journal-title":"Am J Pathol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/jps.20783","article-title":"In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver","volume":"96","author":"Katoh","year":"2007","journal-title":"J Pharm Sci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/hep.20657","article-title":"Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera","volume":"41","author":"Meuleman","year":"2005","journal-title":"Hepatology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jhep.2010.03.024","article-title":"Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice","volume":"53","author":"Vanwolleghem","year":"2010","journal-title":"J Hepatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1086\/651579","article-title":"Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models","volume":"201","author":"Bukh","year":"2010","journal-title":"J Infect Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e0142145","DOI":"10.1371\/journal.pone.0142145","article-title":"Generation of novel chimeric mice with humanized livers by using hemizygous cDNA-uPA\/SCID mice","volume":"10","author":"Tateno","year":"2015","journal-title":"PLoS One"},{"key":"B94","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.bbrc.2008.09.124","article-title":"Establishment of a humanized model of liver using NOD\/Shi-scid IL2Rgnull mice","volume":"377","author":"Suemizu","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B95","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah(-\/-)\/Rag2(-\/-)\/Il2rg(-\/-) mice","volume":"25","author":"Azuma","year":"2007","journal-title":"Nat Biotechnol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"Bissig","year":"2010","journal-title":"J Clin Invest"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1099\/jgv.0.000726","article-title":"Usefulness of humanized cDNA-uPA\/SCID mice for the study of hepatitis B virus and hepatitis C virus virology","volume":"98","author":"Uchida","year":"2017","journal-title":"J Gen Virol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/S0002-9440(10)64835-3","article-title":"Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes","volume":"157","author":"Weglarz","year":"2000","journal-title":"Am J Pathol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/hep.21441","article-title":"Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver","volume":"44","author":"Heo","year":"2006","journal-title":"Hepatology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e77298","DOI":"10.1371\/journal.pone.0077298","article-title":"Chimeric mouse model for the infection of hepatitis B and C viruses","volume":"8","author":"Tesfaye","year":"2013","journal-title":"PLoS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1172\/JCI75456","article-title":"Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model","volume":"124","author":"Carpentier","year":"2014","journal-title":"J Clin Invest"},{"key":"B102","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13027-015-0018-9","article-title":"HCV infection-associated hepatocellular carcinoma in humanized mice","volume":"10","author":"Wang","year":"2015","journal-title":"Infect Agent Cancer"},{"key":"B103","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2011.01.042","article-title":"The reconstituted \u2018humanized liver\u2019 in TK-NOG mice is mature and functional","volume":"405","author":"Hasegawa","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"B104","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbrc.2013.10.040","article-title":"A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections","volume":"441","author":"Kosaka","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B105","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.virusres.2015.11.010","article-title":"Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice","volume":"213","author":"Uchida","year":"2016","journal-title":"Virus Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/hep.22547","article-title":"Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo","volume":"48","author":"Meuleman","year":"2008","journal-title":"Hepatology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/hep.22244","article-title":"Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain","volume":"47","author":"Vanwolleghem","year":"2008","journal-title":"Hepatology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/hep.24171","article-title":"In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus","volume":"53","author":"Meuleman","year":"2011","journal-title":"Hepatology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/hep.24692","article-title":"A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo","volume":"55","author":"Meuleman","year":"2012","journal-title":"Hepatology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/hep.21209","article-title":"Anti-HCV therapies in chimeric scid-Alb\/uPA mice parallel outcomes in human clinical application","volume":"43","author":"Kneteman","year":"2006","journal-title":"Hepatology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e1000291","DOI":"10.1371\/journal.ppat.1000291","article-title":"HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID\/Alb-uPA mice","volume":"5","author":"Joyce","year":"2009","journal-title":"PLoS Pathog"},{"key":"B112","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1124\/dmd.109.028183","article-title":"The uPA(+\/+)-SCID mouse with humanized liver as a model for in vivo metabolism of 4-androstene-3,17-dione","volume":"37","author":"Lootens","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1136\/gutjnl-2015-310300","article-title":"HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice","volume":"65","author":"Prentoe","year":"2016","journal-title":"Gut"},{"key":"B114","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.antiviral.2017.10.015","article-title":"A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo","volume":"148","author":"Desombere","year":"2017","journal-title":"Antiviral Res"},{"key":"B115","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nbt.3179","article-title":"Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody","volume":"33","author":"Mailly","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/hep.27196","article-title":"Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents","volume":"60","author":"Vercauteren","year":"2014","journal-title":"Hepatology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jhep.2012.02.018","article-title":"Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice","volume":"57","author":"Lacek","year":"2012","journal-title":"J Hepatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"E176","DOI":"10.3390\/v8060176","article-title":"Mouse systems to model hepatitis C virus treatment and associated resistance","volume":"8","author":"Mesalam","year":"2016","journal-title":"Viruses"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/gutjnl-2014-309045","article-title":"Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice","volume":"65","author":"Vercauteren","year":"2016","journal-title":"Gut"},{"key":"B120","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.antiviral.2017.01.001","article-title":"Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy","volume":"139","author":"Khera","year":"2017","journal-title":"Antiviral Res"},{"key":"B121","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijpara.2005.10.014","article-title":"Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers","volume":"36","author":"Sacci","year":"2006","journal-title":"Int J Parasitol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/jac\/dkv019","article-title":"Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model","volume":"70","author":"Foquet","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"B123","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1172\/JCI70349","article-title":"Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection","volume":"124","author":"Foquet","year":"2014","journal-title":"J Clin Invest"},{"key":"B124","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/gutjnl-2015-311109","article-title":"Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver","volume":"66","author":"Sayed","year":"2017","journal-title":"Gut"},{"key":"B125","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1053\/j.gastro.2017.09.020","article-title":"Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein","volume":"154","author":"Montpellier","year":"2018","journal-title":"Gastroenterology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.jhep.2014.07.013","article-title":"HCV animal models and liver disease","volume":"61","author":"Vercauteren","year":"2014","journal-title":"J Hepatol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1101\/gad.7.12a.2298","article-title":"Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice","volume":"7","author":"Grompe","year":"1993","journal-title":"Genes Dev"},{"key":"B128","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ng0396-266","article-title":"Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I","volume":"12","author":"Overturf","year":"1996","journal-title":"Nat Genet"},{"key":"B129","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/ng0895-453","article-title":"Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I","volume":"10","author":"Grompe","year":"1995","journal-title":"Nat Genet"},{"key":"B130","doi-asserted-by":"publisher","first-page":"20507","DOI":"10.1073\/pnas.0710528105","article-title":"Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model","volume":"104","author":"Bissig","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B131","doi-asserted-by":"publisher","first-page":"6210","DOI":"10.1073\/pnas.92.13.6210","article-title":"Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo","volume":"92","author":"Lieber","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e78550","DOI":"10.1371\/journal.pone.0078550","article-title":"Mice with chimeric livers are an improved model for human lipoprotein metabolism","volume":"8","author":"Ellis","year":"2013","journal-title":"PLoS One"},{"key":"B133","doi-asserted-by":"publisher","first-page":"23173","DOI":"10.1074\/jbc.M115.662999","article-title":"Functional and biochemical characterization of hepatitis C virus (HCV) particles produced in a humanized liver mouse model","volume":"290","author":"Calattini","year":"2015","journal-title":"J Biol Chem"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e0186213","DOI":"10.1371\/journal.pone.0186213","article-title":"Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy","volume":"12","author":"Burchill","year":"2017","journal-title":"PLoS One"},{"key":"B135","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.antiviral.2017.02.011","article-title":"Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma","volume":"141","author":"Sayed","year":"2017","journal-title":"Antiviral Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"254ra129","DOI":"10.1126\/scitranslmed.3009512","article-title":"Broadly neutralizing antibodies abrogate established hepatitis C virus infection","volume":"6","author":"de Jong","year":"2014","journal-title":"Sci Trans Med"},{"key":"B137","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jcmgh.2017.07.002","article-title":"Analysis of hepatitis C virus particle heterogeneity in immunodeficient human liver chimeric fah-\/- mice","volume":"4","author":"Andreo","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"92587","DOI":"10.1172\/jci.insight.92587","article-title":"Assessing drug efficacy against Plasmodium falciparum liver stages in vivo","volume":"3","author":"Flannery","year":"2018","journal-title":"JCI Insight"},{"key":"B139","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3748\/wjg.v7.i3.324","article-title":"Transplantation of human hepatocytes into tolerized genetically immunocompetent rats","volume":"7","author":"Ouyang","year":"2001","journal-title":"World J Gastroenterol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/0003-4975(94)90367-0","article-title":"Development of tolerance to experimental cardiac allografts in utero","volume":"57","author":"Kline","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1053\/j.gastro.2005.03.015","article-title":"A novel immunocompetent rat model of HCV infection and hepatitis","volume":"128","author":"Wu","year":"2005","journal-title":"Gastroenterology"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2011.01.001","article-title":"A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease","volume":"140","author":"Washburn","year":"2011","journal-title":"Gastroenterology"},{"key":"B143","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm1262","article-title":"Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy","volume":"11","author":"Pajvani","year":"2005","journal-title":"Nat Med"},{"key":"B144","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.1093933","article-title":"Development of a human adaptive immune system in cord blood cell-transplanted mice","volume":"304","author":"Traggiai","year":"2004","journal-title":"Science"},{"key":"B145","doi-asserted-by":"publisher","first-page":"39520","DOI":"10.1038\/srep39520","article-title":"Chronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation","volume":"6","author":"Bility","year":"2016","journal-title":"Sci Rep"},{"key":"B146","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ejphar.2015.03.022","article-title":"Generation of improved mouse models for the study of hepatitis C virus","volume":"759","author":"Douglas","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ajpath.2013.09.008","article-title":"Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice","volume":"184","author":"Gutti","year":"2014","journal-title":"Am J Pathol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.scr.2014.08.006","article-title":"Extensive double humanization of both liver and hematopoiesis in FRGN mice","volume":"13","author":"Wilson","year":"2014","journal-title":"Stem Cell Res"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e0119820","DOI":"10.1371\/journal.pone.0119820","article-title":"A novel mouse model for stable engraftment of a human immune system and human hepatocytes","volume":"10","author":"Strick-Marchand","year":"2015","journal-title":"PLoS One"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1053\/j.gastro.2017.08.034","article-title":"Viral load affects the immune response to HBV in mice with humanized immune system and liver","volume":"153","author":"Dusseaux","year":"2017","journal-title":"Gastroenterology"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e1004032","DOI":"10.1371\/journal.ppat.1004032","article-title":"Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages","volume":"10","author":"Bility","year":"2014","journal-title":"PLoS Pathog"},{"key":"B152","doi-asserted-by":"publisher","first-page":"13022","DOI":"10.1073\/pnas.1000475107","article-title":"Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD\/SCID\/IL2r gamma(null) humanized mice","volume":"107","author":"Shultz","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/2681","article-title":"Selective repopulation of normal mouse liver by Fas\/CD95-resistant hepatocytes","volume":"4","author":"Mignon","year":"1998","journal-title":"Nat Med"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/stem.1359","article-title":"Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem\/progenitor cells","volume":"31","author":"Chen","year":"2013","journal-title":"Stem Cells"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/gutjnl-2014-307856","article-title":"Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infection","volume":"65","author":"Keng","year":"2016","journal-title":"Gut"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e0184127","DOI":"10.1371\/journal.pone.0184127","article-title":"Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model","volume":"12","author":"Zheng","year":"2017","journal-title":"PLoS One"},{"key":"B157","doi-asserted-by":"publisher","first-page":"e1000978","DOI":"10.1371\/journal.ppat.1000978","article-title":"Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors","volume":"6","author":"Bitzegeio","year":"2010","journal-title":"PLoS Pathog"},{"key":"B158","doi-asserted-by":"publisher","first-page":"e1915","DOI":"10.1128\/mBio.01915-16","article-title":"Expanding the host range of hepatitis C virus through viral adaptation","volume":"7","author":"von Schaewen","year":"2016","journal-title":"MBio"},{"key":"B159","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature12427","article-title":"Completion of the entire hepatitis C virus life cycle in genetically humanized mice","volume":"501","author":"Dorner","year":"2013","journal-title":"Nature"},{"key":"B160","doi-asserted-by":"publisher","first-page":"e1799","DOI":"10.1128\/JVI.01799-16","article-title":"Mice expressing minimally humanized CD81 and occludin genes support hepatitis C virus uptake in vivo","volume":"91","author":"Ding","year":"2017","journal-title":"J Virol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/cr.2014.116","article-title":"Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice","volume":"24","author":"Chen","year":"2014","journal-title":"Cell Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1053\/j.gastro.2011.06.010","article-title":"Mouse hepatic cells support assembly of infectious hepatitis C virus particles","volume":"141","author":"Long","year":"2011","journal-title":"Gastroenterology"},{"key":"B163","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1099\/vir.0.027490-0","article-title":"The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae","volume":"92","author":"Stapleton","year":"2011","journal-title":"J Gen Virol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1084\/jem.125.4.673","article-title":"Studies on the transmission of human viral hepatitis to marmoset monkeys","volume":"125","author":"Deinhardt","year":"1967","journal-title":"J Exp Med"},{"key":"B165","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jmv.21013","article-title":"Immunity against the GBV-B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long-lived","volume":"80","author":"Bukh","year":"2008","journal-title":"J Med Virol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1128\/JVI.78.4.2062-2071.2004","article-title":"Development of a GB virus B marmoset model and its validation with a novel series of hepatitis C virus NS3 protease inhibitors","volume":"78","author":"Bright","year":"2004","journal-title":"J Virol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1099\/vir.0.015750-0","article-title":"Molecular evolution of GB virus B hepatitis virus during acute resolving and persistent infections in experimentally infected tamarins","volume":"91","author":"Takikawa","year":"2010","journal-title":"J Gen Virol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.antiviral.2014.12.014","article-title":"Surveying the global virome: identification and characterization of HCV-related animal hepaciviruses","volume":"115","author":"Scheel","year":"2015","journal-title":"Antiviral Res"},{"key":"B169","doi-asserted-by":"publisher","first-page":"11608","DOI":"10.1073\/pnas.1101794108","article-title":"Characterization of a canine homolog of hepatitis C virus","volume":"108","author":"Kapoor","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B170","doi-asserted-by":"publisher","first-page":"e00216","DOI":"10.1128\/mBio.00216-13","article-title":"Identification of rodent homologs of hepatitis C virus and pegiviruses","volume":"4","author":"Kapoor","year":"2013","journal-title":"MBio"},{"key":"B171","doi-asserted-by":"publisher","first-page":"e1003438","DOI":"10.1371\/journal.ppat.1003438","article-title":"Evidence for novel hepaciviruses in rodents","volume":"9","author":"Drexler","year":"2013","journal-title":"PLoS Pathog"},{"key":"B172","doi-asserted-by":"publisher","first-page":"e01933","DOI":"10.1128\/mBio.01933-14","article-title":"Detection of zoonotic pathogens and characterization of novel viruses carried by commensal Rattus norvegicus in New York City","volume":"5","author":"Firth","year":"2014","journal-title":"MBio"},{"key":"B173","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1126\/science.aal1962","article-title":"Mouse models of acute and chronic hepacivirus infection","volume":"357","author":"Billerbeck","year":"2017","journal-title":"Science"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29494","article-title":"Viral persistence, liver disease and host response in hepatitis C-like virus rat model","author":"Trivedi","year":"2017","journal-title":"Hepatology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T17:53:10Z","timestamp":1604253190000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":174,"alternative-id":["10.3389\/fimmu.2018.01032"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01032","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]},"article-number":"1032"}}